Kallikrein cascade and cytokines in inflamed joints

被引:42
作者
Cassim, B
Mody, G
Bhoola, KD
机构
[1] Durban Inst Technol, Fac Hlth, ZA-4000 Durban, South Africa
[2] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Rheumatol, ZA-4013 Congella, South Africa
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
rheumatoid arthritis; kallikreins; kinin receptors; neutrophils; cytokines;
D O I
10.1016/S0163-7258(02)00166-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Rheumatoid arthritis is a chronic multi-system disease of unknown aetiology. The current hypothesis is that an unknown antigen triggers an autoimmune response in a genetically susceptible individual. The predominant pathological change is that of an inflammatory synovitis, characterised by cellular infiltrates and angiogenesis, with subsequent bone and cartilage destruction. These pathological changes are as a result of the activation of a variety of cells, inflammatory mediators, and effector molecules. The pro-inflammatory kinins and cytokines appear to play a central role in the pathogenesis of rheumatoid arthritis. Sufficient evidence exists that establishes a key role for the kallikrein-kinin cascade in inflamed joints. In addition, there appears to be an inter-relationship between cytokines and kinins in the inflammatory process. Kinins induce the release of cytokines, and cytokines have been shown to augment the effects of kinins. This may lead to an enhancement and perpetuation of the inflammatory process. In this review, we report a first study, correlating markers of disease with the kallikrein-kinin cascade and with cytokines. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1 / 34
页数:34
相关论文
共 343 条
[1]   On the structure of the amino-terminal domain ED1 of the B2 receptor [J].
AbdAlla, S ;
Quitterer, U ;
Schroder, C ;
Blaukat, A ;
Horstmeyer, A ;
Dedio, J ;
Reilander, H ;
MullerEsterl, W .
IMMUNOPHARMACOLOGY, 1996, 35 (01) :23-26
[2]  
Abelous JE, 1909, CR SOC BIOL, V66, P511
[3]   BIOLOGY OF MULTIFUNCTIONAL CYTOKINES - IL-6 AND RELATED MOLECULES (IL-1 AND TNF) [J].
AKIRA, S ;
HIRANO, T ;
TAGA, T ;
KISHIMOTO, T .
FASEB JOURNAL, 1990, 4 (11) :2860-2867
[4]  
Al-Haboubi H A, 1986, Adv Exp Med Biol, V198 Pt B, P405
[5]   CYTOKINES IN CHRONIC INFLAMMATORY ARTHRITIS .4. GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR-MEDIATED INDUCTION OF CLASS-II MHC ANTIGEN ON HUMAN-MONOCYTES - A POSSIBLE ROLE IN RHEUMATOID-ARTHRITIS [J].
ALVAROGRACIA, JM ;
ZVAIFLER, NJ ;
FIRESTEIN, GS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :865-875
[6]  
AMANO Y, 1993, MOL PHARMACOL, V43, P176
[7]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[8]   INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160
[9]   INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[10]   PAIN-PRODUCING SUBSTANCE IN HUMAN INFLAMMATORY EXUDATES AND PLASMA [J].
ARMSTRONG, D ;
JEPSON, JB ;
KEELE, CA ;
STEWART, JW .
JOURNAL OF PHYSIOLOGY-LONDON, 1957, 135 (02) :350-370